Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Adenocarcinoma of Lung × osimertinib × Clear all

Phase

Phase 2 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 10 Neoplasm Metastasis 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non-Small Cell Lung Cancer With EGFR Mutation 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 Mesothelioma 1 Lung Diseases 1 Inhibition, Psychological 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Carboplatin 6 Radiotherapy 5 Paclitaxel 5 Erlotinib Hydrochloride 4 pembrolizumab 2 aldesleukin 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 Cyclophosphamide 2 Bevacizumab 2 veliparib 1 trametinib 1 spartalizumab 1 satraplatin 1 osimertinib 1 onartuzumab 1 methyl-4-fluoro-4-deoxyglucose 1 fludarabine phosphate 1 fludarabine 1 anlotinib 1 aflutinib 1 Taxes 1 Sorafenib 1 Radiotherapy, Conformal 1 Radiosurgery 1 Pentostatin 1 Neoadjuvant Therapy 1 Immunotherapy 1 Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04770688 2024-08-15

AUTOMAN

Shanghai Chest Hospital

Phase 1/2 Completed

Adenocarcinoma of Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡